BD Diagnostic Systems, Sparks, MD, announces the release of BBL™ CHROMagar™ Staph aureus, a chromogenic medium that utilizes an enzymatic reaction to isolate and identify Staphylococcus aureus without additional confirmatory testing.

BBL™ CHROMagar™ Staph aureus produces easy to identify mauve-colored colonies with the growth of Staphylococcus aureus. It also requires less technologist time, especially with colonies which exhibit weak hemolysis or atypical appearances on traditional media.

BBL™ CHROMagar™ Staph aureus is the latest addition to the BBL CHROMagar™ media line, which already includes CHROMagar™ Orientation, CHROMagar™ Candida and CHROMagar™ Salmonella. BBL™ CHROMagar™ Staph aureus eliminates the need to subculture to a non-selective medium, thereby reducing consumable costs, enhancing workflow and allowing susceptibility results to be reported earlier. In addition, a recent clinical study has shown an increased recovery of 11% with BBL™ CHROMagar™ Staph aureus compared to Mannitol Salt agar.¹


For more information on BBL™ CHROMagar™ Staph aureus, please call 1-800-638-8663, or contact your BD Diagnostic Systems representative.


1. 2003 ASM poster C-324, Lema et al., The Johns Hopkins Medical Institutions, "Comparison of CHROMagar Staph aureus™ to Conventional Media for the Detection of Methicillin Susceptible and Methicillin Resistant Staphylococcus aureus in Clinical Respiratory Samples"

All trademarks are the property of Becton, Dickinson and Company, except CHROMagar, which is a trademark of Dr. A. Rambach. © 2003 BD.